找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Legal Developments on Cybersecurity and Related Fields; Francisco António Carneiro Pacheco de Andrade,Pedr Book 2024 The Editor(s) (if app

[復(fù)制鏈接]
樓主: 無感覺
11#
發(fā)表于 2025-3-23 09:58:41 | 只看該作者
e towards the religious ‘other’.?The authors thus adopt this framework in the book, as a method of categorising people in a diverse society which in turnhelps readers to understand the nuances of Islam and Muslims in a huge country like Indonesia..978-981-97-1142-0978-981-97-1140-6Series ISSN 2522-8730 Series E-ISSN 2522-8749
12#
發(fā)表于 2025-3-23 16:09:11 | 只看該作者
13#
發(fā)表于 2025-3-23 21:41:45 | 只看該作者
Alessandra Silveirae towards the religious ‘other’.?The authors thus adopt this framework in the book, as a method of categorising people in a diverse society which in turnhelps readers to understand the nuances of Islam and Muslims in a huge country like Indonesia..978-981-97-1142-0978-981-97-1140-6Series ISSN 2522-8730 Series E-ISSN 2522-8749
14#
發(fā)表于 2025-3-24 02:08:33 | 只看該作者
15#
發(fā)表于 2025-3-24 02:51:46 | 只看該作者
Pedro Miguel Fernandes Freitasn evolution towards more aggressive histology, mostly diffuse large B-cell lymphoma (DLBCL) occurs in around 10% of cases. Since prospective phase III trials are lacking, the treatment is not standardised. Currently, the aim of treatment is primarily palliative, and outside of a clinical study, it i
16#
發(fā)表于 2025-3-24 09:21:51 | 只看該作者
17#
發(fā)表于 2025-3-24 14:26:13 | 只看該作者
Arno R. Lodder,Joeri J. Toetn evolution towards more aggressive histology, mostly diffuse large B-cell lymphoma (DLBCL) occurs in around 10% of cases. Since prospective phase III trials are lacking, the treatment is not standardised. Currently, the aim of treatment is primarily palliative, and outside of a clinical study, it i
18#
發(fā)表于 2025-3-24 15:58:59 | 只看該作者
Almudena Vali?o Cesrige Exposition gegenüber neuen Substanzen ausschlaggebend für die Wahl der Behandlung. Bruton-Tyrosinkinase(BTK)-Inhibitoren und der BCL2(?B-cell lymphoma 2“)-Inhibitor allein oder in Kombination mit Rituximab k?nnen in dieser Situation als optimale Therapie für die Mehrzahl der Patienten angesehen
19#
發(fā)表于 2025-3-24 21:30:46 | 只看該作者
20#
發(fā)表于 2025-3-25 00:55:00 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-10 00:07
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
越西县| 连南| 普格县| 乐都县| 沙坪坝区| 老河口市| 綦江县| 宜城市| 通渭县| 大田县| 民县| 东乡| 保定市| 湘潭市| 图们市| 德保县| 静乐县| 桐梓县| 陇西县| 房山区| 禄丰县| 松潘县| 宝山区| 雅安市| 同仁县| 四川省| 玛曲县| 鹤庆县| 石河子市| 福安市| 邓州市| 武宣县| 林甸县| 大渡口区| 怀化市| 特克斯县| 牡丹江市| 扶沟县| 靖西县| 思南县| 阳西县|